Effect of long-term treatment with strontium ranelate on bone strontium content

Bone

Volumn 45, Issue 2, 2009, Pages 200-206

  Bärenholdt, Olaf ^a   Kolthoff, Niels ^a,b   Nielsen, Stig Pors ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bone; Dual X ray absorptiometry (DXA); Dual photon absorptiometry (DPA); Kinetics; Strontium ranelate

Indexed keywords

HYDROXYAPATITE; PLACEBO; STRONTIUM; STRONTIUM RANELATE;

ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; KINETICS; LONG TERM CARE; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PREDICTION; RADIUS; UNSPECIFIED SIDE EFFECT;

ABSORPTIOMETRY, PHOTON; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; ORGANOMETALLIC COMPOUNDS; RADIUS; STRONTIUM; THIOPHENES; TIME FACTORS;

EID: 67649443049     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.04.196     Document Type: Article

References (26)

1. Meunier P.J., Slosman O., Delmas P.D., Sebert J.L., et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. J. Clin. Endocrinol. Metab. (2002) 872060-872066
2. Meunier J., Roux C., Seeman E., et al. Strontium ranelate reduces the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350 (2004) 459-468
3. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., et al. Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis (TROPOS) study. J. Clin. Endocrinol. Metab. 90 (2005) 2816-2822
4. Bruyere O., Roux C., Detilleux J., Slosman D.O., et al. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J. Clin. Endocrinol. Metab. 92 (2007) 3076-3081
5. Vestergaard P., Jorgensen N.R., Mosekilde L., and Schwarz P. Effects of strontium ranelate on bone mineral density and fracture risk - a meta-analysis. Calcif. Tissue Int. 8 suppl. 1 (2007) 151-152
6. Christoffersen J., Christoffersen M.R., Kolthoff N., and Bärenholdt O. Effects of strontium on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone 20 (1997) 47-54
7. Pors Nielsen S., Slosman D., Sørensen O.H., Basse-Cathelinat B., De Casin P., Roux C., and Meunier P.J. Influence of strontium on bone mineral density and bone mineral content measurements by dual-X-ray absorptiometry. J. Clin. Densit. 2 (1999) 371-379
8. Pors Nielsen S., Bärenholdt O., Bärenholdt-Schiøler C., Mauras Y., and Allain P. Noninvasive measurement of bone strontium. J. Clin. Densit. 7 (2004) 262-268
9. Comar C.L., and Wassermann R.H. Strontium. In: Comar C.L., and Bronner F. (Eds). Mineral metabolism Vol. II. The elements. Part A. Calcium physiology (1964), Academic Press, New York and London
10. Marshall J.H. The power function model. In: Comar C.L., and Bronner F. (Eds). Mineral metabolism, an advanced treatise Vol III (1969), Academic Press, New York and London
11. Bärenholdt O., Pors Nielsen S., and Munck O. Long-term measurements of calcium-47 in man. In: Petursson E. (Ed). Proc. VIIIth Nordic meeting on clinical physics, June 16-18, Reykjavik (1975) 95-97
12. Sambrook P.N., Ansell B.M., Fosters Gumpel J.M., Hesp R., Reeve J., and Zanilli J.M. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Annals Rheum Diseases 44 (1985) 575-579
13. 85Sr as a tracer for skeletal calcium. Calcif. Tissue Int. 35 (1983) 9-15
14. Cohn S.H., Bozzo S.R., Jesseph J.E., Constantinides C., Gusmano E.A., and Robertson J.S. Strontium and calcium skeletal discrimation determined by compartmental analysis. J. Appl. Physiol. 1 (1966) 67-72
15. Nielsen S.P., Bärenholdt O., and Munck O. Intestinal absorption and retention of calcium measured by whole body counting. Calcium metabolism (1975), Springer-Verlag 47-51
16. Nielsen S.P., Bärenholdt O., and Munck O. Fractional intestinal absorption and retention of calcium measured by whole body counting. Application of a power function model. Scand. J. Clin. Lab. Invest. 35 (1975) 197-203
17. 85Sr kinetics. J. Bone Miner. Res. 6 (1987) 479-489
18. Walser M. Renal excretion of alkaline earths. In: CL Comar F. (Ed). Mineral metabolism Vol. III. Calcium physiology (1969), Academic Press, New York and London
19. Dahl S.G., Allain P., Marie P.J., et al. Incorporation and distribution of strontium in bone. Bone 28 (2001) 446-453
20. Blake G.M., and Fogelman I. Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment. J. Bone Miner. Res. 21 (2006) 1417-1424
21. S. Ortolani, M. Diaz-Curiel. Strontium ranelate: changes in BMD one year after treatment discontinuation. J Bone Miner Res. Poster. 28th Annual Meeting of the ASBMR 15-19 September 06, Philadelphia (USA). 2006.
22. Kolthoff N., Eiken P., Kristensen B., and Pors Nielsen S. Bone mineral changes during pregnancy and lactation. A longitudinal cohort study. Clin. Sci. 4 (1998) 405-412
23. Farley D., Boivin G., Panczer G., Lalande A., and Meunier P.J. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J. Bone Miner. Res. 20 (2005) 1569-1578
24. Marie P.J., Hott M., Modrowski D., De Pollak C., et al. A uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J. Bone Miner. Res. 8 (1993) 607615
25. Pors Nielsen S., Bärenholdt O., Hermansen F., and Munck-Jensen N. Magnitude and pattern of skeletal response to long-term continuous and cyclic sequential oestrogen/progestin treatment. Brit. J. Obst. Gyn. 101 (1994) 319-324
26. Pors Nielsen S. The fallacy of BMD: a critical review of the diagnostic use of dual-X-ray absorptiometry. Clin. Rheumatol. 19 (2000) 174-183